The first assessment of the 3rd Cancer Plan has just been given to François Hollande. Oral chemotherapy continues to progress in France. But the organization is struggling to get established.
The follow-up report of 3th Plan Cancer was presented to President François Hollande on February 13 by Minister of Health Marisol Touraine, Geneviève Fioraso – Secretary of State for Higher Education and Research – and Prof. Agnès Buzyn, President of the National Institute Cancer (INCa). The many projects started tend to stall.
A necessary organization
“Changes in the care pathway for cancer patients favor home care”, underlines the monitoring report. Oral chemotherapy is a big part of this. This is why the Cancer Plan makes its development a major objective. But in reality, the application is more difficult.
“The development of oral chemotherapy, the benefits of which, for patients as well as for the community, are numerous, raises essential questions on the quality and safety of care, compliance or management of side effects, giving a much greater role to important to the patient, ”acknowledge the authors of the report. “In addition, this calls into question our care organization, which remains largely designed for chemotherapy treatments delivered during hospital stays. The dossier therefore calls for a reorganization of the supply of care and coordination between the various health professionals.
Many delays
Various projects relating to oral chemotherapy have been initiated. Some must take stock, others initiate the necessary changes in the health care offer. But most have fallen slightly behind. Thus, the first assessment of home hospitalization, of which oral chemotherapy is an integral part, has not yet started.
Two inventories took a “minor delay.” The first concerns the conditions of prescription and delivery of oral chemotherapy. The second focuses on the pathways of patients. In the end, only the recommendations intended for health professionals will be delivered on time, in March 2015. We are still far from the objective set by the Cancer Plan, which wants 95% of oral chemotherapy to be the subject of guides. nationals in 2018.
Despite the delays, oral chemotherapy continues to evolve. In July 2014, the General Directorate of Healthcare Provision (DGOS) launched an experimentation phase aimed at improving city-hospital coordination. 10 teams from city care were added to the 35 already recruited. They work in particular on the development of outpatient care. In the same vein, the Regional Health Agencies (ARS) received funding.
.
